Not only is on-demand administration of doxycycline after condomless sex (doxyPEP) an effective prophylaxis against bacterial sexually transmitted infections (STIs), but patients are embracing it, according to new data presented at CROI 2024, in Denver.
The results of several trials of doxyPEP, including the doxyPEP study, were so compelling the CDC recommended doxyPEP be offered to people who would benefit. DoxyPEP was a randomized controlled trial with men who have sex